Welcome to Sott.net
Sun, 24 Jan 2021
The World for People who Think

Health & Wellness


Chlamydia & gonorrhea rates in younger US women SOAR, as health experts raise alarm over drop in tests during pandemic

Chlamydia test
© Getty Images/Peter Dazeley
Rates of chlamydia and gonorrhea have skyrocketed among young women in the US in recent years. Health experts are concerned infections are now going undiagnosed after testing dropped precipitously as a result of the pandemic.

According to the results of a recent study conducted by Quest Diagnostics, published in the American Journal of Preventive Medicine, there has been a 50 percent spike in positive cases among women aged 25 to 30.

The research examined 17 million laboratory samples from women aged 12 to 30, taken between 2010 and 2017.

While there was a noticeable decline in cases of both chlamydia and gonorrhea among sexually active teenagers from ages 12 to 17, the 18-to-21 category saw a 21 percent increase in sexually transmitted infections (STIs).

SOTT Logo Radio

Objective:Health - The True Cost of the Covid Lockdown

O:H header
The Covid lockdown was ostensibly instituted to both "flatten the curve" and save lives, all evidence showing it succeeded in neither. What it has done instead is increase deaths and have a massively devastating effect on multiple levels of society. The economy, public health, education, the very social fabric of communities - all have been negatively impacted by the misguided (or devious) lockdown.

On this episode of Objective:Health, we talk about the true cost of the Covid lockdown including suicides, domestic violence, mental health, delayed medical procedures and more. Join us for a scintilating conversation on how the "great reset" is leaving us all much worse off.

And check us out on Brighteon and lbry.tv!

For other health-related news and more, you can find us on:

♥Twitter: https://twitter.com/objecthealth
♥Facebook: https://www.facebook.com/objecthealth/
♥Brighteon: https://www.brighteon.com/channel/objectivehealth

♥And you can check out all of our previous shows (pre YouTube) here.

Running Time: 00:36:45

Download: MP3 — 33.7 MB


Brucellosis outbreak in China linked to animal vaccine factory sickens thousands

china mask
© AP
Brucellosis also goes by the name of Malta fever or Mediterranean fever and can cause symptoms including headaches, muscle pain, fever and fatigue.
Another outbreak in China has sparked a wave of concern among authorities after thousands of people in the northern part of the country tested positive for a bacterial infection. The infection spread among people working in a state-owned biopharmaceutical plant in Lanzhou city, which produces animal vaccines after a leak occurred last year.

Here's all you need to know about Brucellosis outbreak:

Comment: See also: Also check out SOTT radio's:


Ben Swann: Vaccine study halted over "serious adverse side effects" - UPDATE: AstraZeneca jab showing adverse effects

ben swann reality check
In this episode of Reality Check, host Ben Swann looks into the recent AstraZeneca Covid vaccine study that had to pause the trial due to one participant coming down with serious side effects from the vaccine. The experimental vaccine is drawing scrutiny after a participant in clinical trials was diagnosed with transverse myelitis, a rare neurological condition associated with viral infections in which the spinal cord is inflamed.

Comment: See also: UPDATE 17/09/2020: An AstraZeneca vaccine volunteer developed severe complications after two doses:
A previously healthy 37-year-old woman was hospitalized this month after receiving two injections of the pharmaceutical giant's new vaccine, where it was determined she developed transverse myelitis, a rare neurological ailment caused by inflammation of the spine, according to an internal AstraZeneca safety report obtained by CNN.

Though the report states the woman, who has not been identified by name, had no adverse reaction after her first dose in early June, she began to experience neurological symptoms some two weeks after her second jab in August. During a jog on September 2, the volunteer "had a trip (not fall) with a jolt," the document says, while the next day she reported difficulties walking, weakness in her arms, impaired motor control over her hands, a headache and reduced feeling in her torso. She was hospitalized September 5 and diagnosed with "confirmed transverse myelitis" soon after.

In a previously released "participant information sheet", the company acknowledged that a volunteer had "developed unexplained neurological symptoms", however despite pausing its trial worldwide after the incident, AstraZeneca said the reaction was "considered unlikely to be associated with the vaccine or there was insufficient evidence to say for certain that the illnesses were or were not related to the vaccine." The company has since resumed trials in the UK and Brazil, but they remain on hold in the US until health authorities determine it is safe to continue, according to Moncef Slaoui, chief adviser to the US government's Covid-19 vaccine effort.


Injectable biochip for SARS-CoV-2 detection near FDA approval

injectable biochip
The Silicon Valley company, Profusa,1 in partnership with the U.S. Defense Advanced Research Projects Agency (DARPA),2 has created an injectable biosensor capable of detecting the presence of an infection in your body.3

In early August 2019, months before COVID-19 became a household word, DARPA granted Profusa additional funding "to develop an early identification system to detect disease outbreaks, biological attacks and pandemics up to three weeks earlier than current methods."4

As discussed in "Will New COVID Vaccine Make You Transhuman?" we appear to stand at the doorway of a brave new world in which man is increasingly merged with technology and artificial intelligence, and COVID-19 may well be the key that opens that door, in more ways than one.

Comment: See also:


Good news! Butter booms to sales not seen since 1965

Consumers have been flocking back to butter.

That's because evidence continues to mount that all dietary fats are not equal. Foods such as unprocessed meats, dark chocolate, and whole fat dairy may be relatively high in saturated fat content, but they show no association with heightened cardiovascular risk or mortality. If that weren't enough, there is now evidence that saturated fat intake may actually be associated with a lower risk of experiencing stroke.

As a result, the average American consumed 6.2 pounds of butter in 2019. The last time butter consumption topped that mark, Lyndon Johnson was the U.S. president.

Comment: See also:

SOTT Logo Radio

Objective:Health: - Health News Censorship on the Rise

O:H header
Censorship on social media is nothing new, but it seems like the major platforms are having a field day with it lately. It's usually in the realm of politics, but recently a few notable alternative health sites and personalities have been censored.

Green Med Info, a truly great site which documents published, peer-reviewed studies on the evidence for natural and alternative medicines, was recently given the boot from Instagram and Linked-In (to which everyone replied, "Linked-In?"). Dr. Mercola has had multiple videos recently banned from YouTube and controversial carnivore advocate Mikhaila Peterson has been demonetized on the platform. Also, during the Joe Rogan podcast's recent switch to Spotify, Mikhaila's interview was among the many that were conspicuously absent.

Is there another purge coming? What is so dangerous about this health information that we need to be prevented from accessing it? Join us for a rousing discussion about social media censorship of alternative health.

And check us out on Brighteon!

For other health-related news and more, you can find us on:

♥Twitter: https://twitter.com/objecthealth
♥Facebook: https://www.facebook.com/objecthealth/
♥Brighteon: https://www.brighteon.com/channel/objectivehealth

♥And you can check out all of our previous shows (pre YouTube) here.

Running Time: 00:34:18

Download: MP3 — 31.4 MB


AstraZeneca suspends US COVID-19 vaccine trial amid serious concerns, trials continue in South Africa

AstraZeneca lab vaccine

AstraZeneca COVID-19 vaccine trial suspended in US for at least several more days amid concerns over serious complication
AstraZeneca COVID-19 vaccine trial suspended in US for at least several more days amid concerns over serious complication The experimental vaccine is drawing scrutiny after a participant in clinical trials was diagnosed with transverse myelitis, an inflammatory syndrome.

The US clinical trial of AstraZeneca's COVID-19 vaccine will be suspended for the next several days as the US Food and Drug Administration investigates a potential side effect, according to Reuters.

Sources told the news agency on Monday that enrollment in the trial was not being reopened "until at least midweek," pending the investigation.

The FDA did not immediately respond to a request for comment.

Comment: Meanwhile in South Africa, AstraZeneca, for some reason, is going ahead with the vaccine trials knowing full well the potential harm this could cause:
Astrazeneca has resumed COVID-19 vaccine trials in South Africa, more than a week after tests were placed on hold due to serious side effects in a participants in Britain, an official at the country's Department of Health told Reuters on Tuesday.
However we've seen this kind of medical malpractice in developing countries numerous times before: New oral polio vaccine to BYPASS key clinical trials as vaccine caused outbreaks overtake wild polio

It's also worth noting that, Russia already has a vaccine that has passed trials with few complications and is now in the production line. This says a lot about the current state of medical research that other countries are continuing to waste time and money on an problem that has already been solved, all because of political maneuvering: Russia produces first batch of COVID-19 vaccine, 500 million doses available by January

Also check out SOTT radio's:


How ultra-processed food is ageing our cells

ultraprocessed foods

Ultra processed foods including things like mass-produced bread, ready meals, instant noodles, fizzy drinks, sweets and crisps
A growing body of research suggests that cooking our own food could be the secret to a long and healthy life

Whenever Dr Yasmin Razak sees a healthy patient in their 90s at her London GP surgery, she has a question for them. "I ask what they do to look after themselves. They say every time: 'I make my own food and I don't eat out'. They either have an allotment or grow food in their garden."

For anyone searching for the secret to long life, the answer looks straightforward, then. Dr Razak's nonagenarians, who also cite regular walks, do not rely on the convenience foods, takeaways and ready meals that form a staple of so many British diets today.

Comment: See also:


Sputnik V launched: Russia dispatches first batches of pioneering Covid-19 vaccine to all of its 85 regions

vaccine Russia
© Sputnik/Russian Healthcare Ministry
Packs with the world's first vaccine against COVID-19 registered in Russia.
Russia has sent out the initial batches of the world's first registered coronavirus vaccine to all parts of its vast territory, as authorities test the delivery system of the much-needed drug.

The formula is expected to be delivered on Monday, said Russia's Health Minister Mikhail Murashko.

"The first small batches have already been shipped," Murashko said, explaining that the government is testing the supply chain to ensure a robust delivery system across the country's 85 regions. As well as testing the efficacy and safety of the vaccine itself, the government believes it is paramount to ensure the efficient distribution to citizens, especially to those at high risk.

Russia's homegrown Covid-19 formula is currently in the third and final stage of clinical trials, in which 40,000 Muscovites will take part. While three-quarters will receive the jab, another quarter will be given a placebo. On Wednesday, Moscow's Deputy Mayor Anastasia Rakova announced that testing had begun, and over 35,000 residents had applied.

"Clinical trials have begun in Moscow," Murashko said, adding that the ministry had also created "the world's first mobile application" that allows participants to "report on their condition" throughout the lengthy trial period.